Engineering Mucosal RNA Interference in Vivo

Molecular Therapy

Volumn 14, Issue 3, 2006, Pages 336-342

  Zhang, Yingjie ^a   Cristofaro, Patricia ^a   Silbermann, Rebecca ^a   Pusch, Oliver ^a   Boden, Daniel ^b   Konkin, Tamako ^c   Hovanesian, Virginia ^d   Monfils, Paul R ^d   Resnick, Murray ^c   Moss, Steven F ^c   Ramratnam, Bharat ^a  

^a Laboratory of Retrovirology   (United States)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

gene therapy; microbicide; RNA interference

Indexed keywords

INTERFERON; LIPOSOME; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL BASED GENE THERAPY; COLITIS; ENTERITIS; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC CODE; GENETIC ENGINEERING; HEMATOPOIETIC CELL; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; RECTUM MUCOSA; RNA INTERFERENCE; SOMATIC GENE THERAPY; UTERINE CERVIX MUCOSA; VAGINA MUCOSA;

ANIMALS; CERVIX UTERI; FEMALE; GENE EXPRESSION; GENE THERAPY; INFLAMMATORY BOWEL DISEASES; LIPOSOMES; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; RECTUM; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA; VAGINA;

MURINAE;

EID: 33746913567     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.04.001     Document Type: Article

References (30)

1. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
2. Brummelkamp T.R., Bernards R., and Agami R. Effective expression of small interfering RNA in human cells. Science 296 (2002) 550-553
3. Lee N.S., et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20 (2002) 500-505
4. Boden D., et al. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol. Ther. 9 (2004) 396-402
5. Hommel J.D., et al. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9 (2003) 1539-1544
6. Sorensen D.R., Leirdal M., and Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327 (2003) 761-766
7. Xia H., Mao Q., Paulson H.L., and Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20 (2002) 1006-1010
8. Song E., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (2003) 347-351
9. Bitko V., Musiyenko A., Shulyayeva O., and Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11 (2005) 50-55
10. Zhang W., et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11 (2005) 56-62
11. Palliser D., et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439 (2005) 89-95
12. Murano M., et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin. Exp. Immunol. 120 (2000) 51-58
13. Vlassov V.V., Karamyshev V.N., and Yakubov L.A. Penetration of oligonucleotides into mouse organs through mucosa and skin. FEBS Lett. 327 (1993) 271-274
14. Elbashir S.M., Harborth J., Weber K., and Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26 (2002) 199-213
15. Chiu Y.L., et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol. 11 (2004) 1165-1175
16. Grunweller A., Gillen C., Erdmann V.A., and Kurreck J. Cellular uptake and localization of a Cy3-labeled siRNA specific for the serine/threonine kinase Pim-1. Oligonucleotides 13 (2003) 345-352
17. Mack M., et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166 (2001) 4697-4704
18. Fedorov Y., et al. Different delivery methods-Different expression profiles. Nat. Methods 2 (2005) 241
19. Gao D., et al. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut 54 (2005) 70-77
20. Armuzzi A., et al. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur. Rev. Med. Pharmacol. Sci. 8 (2004) 231-233
21. Sledz C.A., et al. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 (2003) 834-839
22. Bridge A.J., et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34 (2003) 263-264
23. Hornung V., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
24. Judge A.D., et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
25. Heidel J.D., et al. Lack of interferon response in animals to naked siRNAs. Nat. Biotechnol. 22 (2004) 1579-1582
26. Soutschek J., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
27. Kim D.H., et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23 (2005) 222-226
28. Siolas D., et al. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23 (2005) 227-231
29. Jiankuo M., et al. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft. J. Immunol. 170 (2003) 1556-1565
30. Boden D., et al. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77 (2003) 11531-11535